Blog

All the latest news from Check4Cancer
Ask the Expert: BRCA1 and BRCA2 gene testing
Sarah Beck, a Registered Genetic Counsellor at Check4Cancer, answers your questions about the risks of inheriting and the ben...
Cervical screening during lockdown: Don’t fear the smear!
Once again, the UK is in lockdown with the National Health Service under worrying strain, resulting in non-urgent services be...
Mr Jullien Brady answers some of the most pressing questions around cervical cancer in the fourth of our ‘Ask the Expert’ blog series
Ask the Expert: HPV and Cervical Cancer In the fourth of our Ask the Expert series, we spoke to Mr Jullien Brady, Consu...
How you can reduce your cancer risk for 2021?
The festive season may look very different this year but this Christmas and New Year is still a great opportunity to make som...
Check4Cancer’s year in review – 2020
Never before has the word unprecedented been so used or so apt, and 2020 has truly been an unprecedented year. In January 202...
The GALLERI trial - exciting development or unwelcome distraction?
Professor Gordon Wishart, Chief Medical Officer at Check4Cancer gives his comment on the recent announcement by the NHS on th...
Ask the Expert: What is the OneStop Breast cancer diagnostic service?
Mr Debashis Ghosh, Consultant Breast Surgeon at Check4Cancer’s OneStop Breast Clinic network, answers your questions and pr...
Is Lockdown No 2 justified ?
Professor Gordon Wishart, Chief Medical Officer at Check4Cancer gives his thoughts on Lockdown No2 and it's likely effec...
Professor Sam Janes answers some of the most pressing questions around lung cancer in the third of our ‘Ask the Expert’ blog series
Ask the Expert: Lung Cancer  Professor Sam Janes answers some of the most pressing questions around lung cancer in the ...
Doctors fear for the continued actions of the Government
Professor Gordon Wishart, Chief Medical Officer at Check4Cancer writes for The Express on why SAGE has to change its presenta...
Male Cancer Awareness - know the facts and get checked
With one in two people now predicted to get cancer in their lifetime, cancer impacts everyone directly or indirectly, and the...
An Audit of Check4Cancer’s OneStop Breast Clinic network confirms continued excellence in the private sector
Check4Cancer, the reliable and trusted provider of early cancer detection and genetic services in the UK, delivers audit resu...
BeBreastAware - Mammograms
Around one in seven women in the UK are diagnosed with breast cancer¹ at some point in their lives. Early detection rem...
Resetting the consultant dynamic
In the third and final part of a three article series with Laing Buisson Healthcare Markets, Professor Gordon Wishart and Phi...
Be BreastAware - find out about the signs and symptoms of breast cancer
Breast Cancer Awareness Month, marked in countries across the world every October, helps to increase attention and support fo...
Coronavirus: Hidden toll of 25,000 extra deaths in private homes since virus took hold
Between March and September there were 25,000 excess deaths in private homes in England, with the vast majority not linked to...
Covid chaos offers chance to revamp independent practice
Professor Gordon Wishart, chief medical officer at Check4Cancer and Philip Housden, managing director of Housden Group analys...
Male Breast Cancer - know the facts and get checked
Male breast cancer Usually thought of as a disease seen only in women, male breast cancer is a rare but real risk, most ofte...
Professor Simon Russell answers some of the most pressing questions around breast cancer in the second of our ‘Ask the Expert’ blog series
Ask the Expert: Breast Cancer In the second of our Ask the Expert blog series, Professor Simon Russell, Consultant Oncologis...
Professor Richard Hindley answers some of the most pressing questions around prostate cancer in the first of our ‘Ask the Expert’ blog series
Ask the Expert: Prostate Cancer Professor Richard Hindley answers some of the most pressing questions around prostate cancer...
Screening and diagnostics: what’s the difference?
When it comes to cancer, the terms ‘screening’ and ‘diagnostics are often – incorrectly – used interchangeably. Can...
How the pandemic is changing traditional healthcare relationships in the UK
The second of three articles in Laing Buisson Healthcare Markets by Professor Gordon Wishart and Philip Housden, managing dir...
Check4Cancer receives a double nomination in the 2020 Laing Buisson Healthcare Awards
Professor Gordon Wishart is recognised as a ‘Rising Star’ finalist and Check4Cancer is shortlisted as a finalist in the â...
Check4Cancer launches online service to provide fast cancer screening as thousands of people go untested in the Covid-19 pandemic
Check4Cancer, the provider of early cancer detection and genetic services, has launched its new brand and website bringing to...